FishForPharma is a Marie Curie Initial Training Network funded by the 7th Framework People Programme of the European Commission. The project will run for 4 years from January 2012. It brings together leading European research groups that have pioneered the use of zebrafish infection models and partners from the Biotech and Pharma sectors that aim to commercialise zebrafish tools for biomedical applications.
The European network on Fish Biomedical Models (EUFishBioMed) is a network devoted to fostering exchange of information, techniques, materials and expertise within and beyond the fish community. We are dedicated to promoting the further development of the technologies and versatilities of fish models in biomedical research and to make these accessible to other users, such as the medical, pharmaceutical and industrial communities. Currently more than 300 Europe-based research groups are linked by this network. An overview, information on the specific expertise, and the contact details of each laboratory's PI (principal investigator) is offered via the coordinating institution (KIT) upon request. The network EuFishBioMed is supported by the European Union through COST Action BM0804 (2009-2013.
EUMORPHIA was an FP6 integrated project involving development of new approaches in phenotyping, mutagenesis and informatics leading to improved characterisation of mouse models for the understanding of human physiology and disease. The focus was on development, standardisation and dissemination of primary and secondary phenotyping protocols for all body systems in the mouse. The project piloted novel approaches to gene-driven mutagenesis and was supported by new informatics tools for the acquisition, dissemination and querying of phenotype data.
Bridging Genomes: An integrated genomic approach toward genetic improvement of aqua cultured fish species
BRIDGEMAP was an FP6 STREP project that focused on the genomics of the sea bream (Sparus auratus).
ZF-MODELS was an FP6 integrated project that aimed to exploit the advantages of the zebrafish to produce knowledge, technology and materials in the form of disease models, drug targets and insight into pathways of gene regulation applicable to human development and disease.